Medication info
Rivastatin 2 mg (Pitavastatin Calcium Hydrate)

Rivastatin 2 mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›200mg / 1 tablet
Manufacturer / importer
K.S. Pharma Co., Ltd.
Appearance
Very pale yellowish-red round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202002753 · Approved 2020.04.20 · Insurance code 059000670

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1 to 2 mg of pitavastatin calcium orally once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goals, and the patient's response, adjust the dose as appropriate at intervals of 4 weeks or longer. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
K.S. Pharma Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It also increases HDL cholesterol levels, positively impacting cardiovascular health. It is effective in improving dyslipidemia when used in conjunction with dietary modifications. This medication is used to treat familial and non-familial hypercholesterolemia and dyslipidemia as classified by Fredrickson.

How to take

Adult dose

Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1 to 2 mg of pitavastatin calcium orally once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goals, and the patient's response, adjust the dose as appropriate at intervals of 4 weeks or longer. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be used in certain patients. For example, patients who have an allergy to this drug, those with active liver disease or persistently elevated liver enzyme levels of unknown cause, patients with severe liver impairment or biliary obstruction, and patients taking cyclosporine should avoid this medication. Furthermore, women who have myopathy or are pregnant or may become pregnant, nursing mothers, and children are advised against using this medication. This product contains lactose, and individuals with lactose intolerance or certain genetic conditions should also avoid it. Patients with impaired kidney function or a history of liver impairment should use this medication cautiously. Co-administration with fibrates or niacin may cause muscle damage and worsening kidney function, so avoiding these combinations is advisable. People who consume large amounts of alcohol, those with hypothyroidism, elderly individuals, and those with muscle weakness should also exercise caution. During treatment with this medication, side effects such as muscle pain, weakness, abdominal pain, rash, and itching may occur. Symptoms of liver dysfunction, blood abnormalities, and decreased kidney function may also arise, necessitating regular testing. If muscle pain or tenderness becomes severe, discontinue use immediately and consult a physician. This drug is used for treating hypercholesterolemia, and accurate diagnosis, dietary adjustments, and exercise therapy should be undertaken beforehand. Regular testing of blood lipid levels during treatment is essential to confirm its effectiveness, as is periodic liver function testing. This drug can interact with specific medications, so caution is warranted when taken with cyclosporine, fibrates, niacin, erythromycin, etc. Taking these medications together may significantly increase the risk of muscle damage and worsening kidney function, therefore consulting with a physician or pharmacist is advised. Elderly patients are at higher risk for side effects due to decreased bodily functions and should take caution while using it. Pregnant or nursing individuals should not take this medication, and women of childbearing potential should discontinue immediately upon confirmation of pregnancy. The safety for children has not been established, so it's best not to use it. Lastly, this medication should be stored out of the reach of children and kept in its original container to maintain quality.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 81 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • dry mouth
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • increased urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • asthenia
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • elevated serum potassium and phosphorus
  • dysgeusia
  • positive antinuclear antibody
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that blocks light, and the storage temperature should be maintained at room temperature between 1 degree and 30 degrees. Proper storage helps maintain the medication's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

Very pale yellowish-red round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.